Eupraxia Pharmaceuticals, Inc. (EPRX)
7.50
+0.05
(+0.67%)
USD |
NASDAQ |
Sep 03, 16:00
7.44
-0.06
(-0.80%)
After-Hours: 06:56
Eupraxia Pharmaceuticals Net Income (Quarterly) : -14.49M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.49M |
| March 31, 2026 | -12.63M |
| December 31, 2025 | -16.72M |
| September 30, 2025 | -6.369M |
| June 30, 2025 | -8.748M |
| March 31, 2025 | -6.767M |
| December 31, 2024 | -7.532M |
| September 30, 2024 | -5.991M |
| June 30, 2024 | -6.064M |
| March 31, 2024 | -6.157M |
| September 30, 2023 | -4.896M |
| June 30, 2023 | -9.506M |
| March 31, 2023 | -3.956M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.691M |
| September 30, 2022 | -4.127M |
| June 30, 2022 | -4.918M |
| March 31, 2022 | -2.968M |
| December 31, 2021 | -2.996M |
| September 30, 2021 | -4.075M |
| June 30, 2021 | -4.557M |
| March 31, 2021 | -6.999M |
| December 31, 2020 | -0.1073M |
| September 30, 2020 | -0.5463M |
| December 31, 2019 | -0.5399M |
| September 30, 2019 | -1.332M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -5.408M |
| ProMIS Neurosciences, Inc. | -11.73M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.49M |
| EPS Diluted (Quarterly) | -0.2278 |
| Enterprise Value | 387.16M |
| Earnings Yield | -13.13% |
| Normalized Earnings Yield | -13.13 |